Nantahala Capital Management, LLC 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 77,337 1.700% |
-141,036 (-64.58%) |
Filing |
| 2023-02-14 4:58 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 218,373 6.100% |
-45,150 (-17.13%) |
Filing |
| 2022-02-14 08:30 am Purchase |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 263,523 7.900% |
263,523 (New Position) |
Filing |